Stoke Therapeutics Eulerpool Ziņas

Stoke Therapeutics Akciju Ziņas

Stoke Therapeutics tiek uzmanīgi vēroti no žurnālistu un investoru puses visā pasaulē. Jaunākās Stoke Therapeutics ziņas mēs apkopojam šeit.

• 5. decembris ·

  Yahoo
  STOK Shares Up on FDA's Breakthrough Tag for Dravet Syndrome Drug
• 4. decembris ·

  Yahoo
  Stoke Therapeutics Receives FDA Breakthrough Therapy Designation for Zorevunersen for the Treatment of Dravet Syndrome
• 2. decembris ·

  Yahoo
  Stoke Therapeutics Announces Plans to Present New Data that Support Zorevunersen as Potentially the First Disease-Modifying Medicine for Dravet Syndrome at the American Epilepsy Society 2024 Annual Meeting
• 26. novembris ·

  Yahoo
  An RNA biotech draws the blueprint for a late-stage Dravet syndrome trial and beyond
• 20. novembris ·

  Yahoo
  Stoke Therapeutics (STOK) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
• 8. novembris ·

  Yahoo
  Wall Street Analysts Believe Stoke Therapeutics (STOK) Could Rally 66.84%: Here's is How to Trade
• 6. novembris ·

  Yahoo
  Need To Know: Analysts Are Much More Bullish On Stoke Therapeutics, Inc. (NASDAQ:STOK) Revenues
• 1. novembris ·

  Yahoo
  Fortrea Holdings Inc. (FTRE) Reports Next Week: Wall Street Expects Earnings Growth
• 13. oktobris ·

  Yahoo
  Stoke Therapeutics assumed with an Outperform at Leerink
• 12. oktobris ·

  Yahoo
  Stoke Therapeutics, Inc (STOK): Pioneering RNA Medicine for Genetic Diseases